Effects of agitation speed on theex vivoexpansion of cord blood hematopoietic stem/progenitor cells in stirred suspension culture
Source abstract
Abstract
The mononuclear cells were cultivated in stirred flasks at different agitation speeds of 30 rpm, 45 rpm, 60 rpm and 80 rpm. At the agitation speed of 30 rpm, total cells achieved higher expansion folds and the CFC density increased. When at higher agitation speed of 60 rpm or 80 rpm, the number of cells dropped rapidly and characteristics of hematopoietic stem/progenitor cells (HSPCs) were not maintained. Moreover, the culture duration of 6-9 days was better for HSPCs ex vivo expansion. These data indicated that HSPCs should be cultured at relatively low agitation speed and for a short-term period when cultured in stirred suspension system.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Hematopoietic Stem Cell Transplantation · Mesenchymal stem cell research · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (25)
Show source-provided references
1. Bornstein R · Stem Cells · 2005 · 23 · 32410.1634/stemcells.2004-0047 ↗
2. Cabral JMS · Biotechnol Lett · 2001 · 23 · 74110.1023/A:1010350215989 ↗
3. Cabrita GJM · Trends Biotechnol · 2003 · 21 · 23310.1016/S0167-7799(03)00076-3 ↗
4. Cairo M · Blood · 1997 · 90 · 466510.1182/blood.V90.12.4665 ↗
5. Collins P · Biotechnol Bioeng · 1998 · 59 · 53410.1002/(SICI)1097-0290(19980905)59:5<534::AID-BIT2>3.0.CO;2-B ↗
6. 10.1089/ten.2006.12.323310.1089/ten.2006.12.3233 ↗
7. Dahlberg A · Blood · 2011 · 117 · 608310.1182/blood-2011-01-283606 ↗
8. Fasouliotis SJ · Eur J Obstet Gynaecol Reprod Biol · 2000 · 90 · 1310.1016/S0301-2115(99)00214-6 ↗
9. Fok E · Stem Cells · 2005 · 23 · 133310.1634/stemcells.2005-0112 ↗
10. Gilbertson J · Biotechnol Bioeng · 2006 · 94 · 78310.1002/bit.20900 ↗
11. Gluckman E · N Eng J Med · 1989 · 32 · 117410.1056/NEJM198910263211707 ↗
12. Goussetis E · Blood Cells Mol Dis · 2010 · 44 · 10710.1016/j.bcmd.2009.10.011 ↗
13. Highfill J · Biotechnol Bioeng · 1996 · 50 · 51410.1002/(SICI)1097-0290(19960605)50:5<514::AID-BIT5>3.0.CO;2-I ↗
14. Horner M · Biotechnol Prog · 1998 · 14 · 68910.1021/bp980067e ↗
15. Jelinek N · Eng Life Sci · 2002 · 2 · 1510.1002/1618-2863(200201)2:1<15::AID-ELSC15>3.0.CO;2-5 ↗
16. 10.1002/(SICI)1097-0290(19991205)65:5<589::AID-BIT12>3.0.CO;2-S10.1002/(SICI)1097-0290(19991205)65:5<589::AID-BIT12>3.0.CO;2-S ↗
17. King JA · Curr Opin Chem Biol · 2007 · 11 · 39410.1016/j.cbpa.2007.05.034 ↗
18. Koller M · J Hematother · 1995 · 4 · 15910.1089/scd.1.1995.4.159 ↗
19. 10.1016/j.jbiotec.2006.01.02010.1016/j.jbiotec.2006.01.020 ↗
20. Martin I · Trends Biotechnol · 2004 · 22 · 8010.1016/j.tibtech.2003.12.001 ↗
21. Rubinstein P · New Engl J Med · 1998 · 339 · 156510.1056/NEJM199811263392201 ↗
22. Schroeder M · Biotechnol Bioeng · 2005 · 92 · 92010.1002/bit.20668 ↗
23. 10.1007/s10529-007-9517-010.1007/s10529-007-9517-0 ↗
24. Youn B · Biotechnol Prog · 2006 · 22 · 80110.1021/bp050430z ↗
25. Youn B · Biotechnol Prog · 2005 · 21 · 98410.1021/bp050059f ↗